$2.67
-0.10 (-3.61%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+384.3% upside
Low Target
$7.67
Average Target
$12.93
High Target
$16.62
Current Price
$2.67
Current
$2.67
$2.67
Target
$12.93
$12.93
$7.67
$12.93 avg
$16.62
Scenario Analysis
Bear Case
$7.67
187.3%
Low target
Base Case
$12.93
+384.3%
Avg target
Bull Case
$16.62
+522.5%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$4.53
-41.1% from high
52-Week Low
$1.90
+40.5% from low
Target vs 52W High
$12.93
+185.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |